Patents by Inventor Edit Hegyi

Edit Hegyi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6803183
    Abstract: In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C10-C24 alkylamino group, the ligands specifically binding endotoxin; and (b) a second component comprising a halogenated quinolone moiety immobilized on an amino-group-containing solid support by the formation of an amide linkage, the first component and the second component being present in the resin at a ratio of from about 20:80 (v/v) to about 80:20 (v/v); and (2) collecting the biological fluid from which pyrogens have been removed. Preferably, the alkylamino group is a stearylamino group, and the ligands are cross-linked and quaternized by reaction with a dibromoalkanol. Preferably, the polymeric support of the first component is agarose in particulate form.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: October 12, 2004
    Assignee: Clarigen, Inc.
    Inventors: Marie-Claude Amoureux, Edit Hegyi, Peter Grandics, Susan Szathmary
  • Publication number: 20040014022
    Abstract: In general, a method for removal of pyrogens from plasma or blood according to the present invention comprises: (1) passing the biological fluid through a resin comprising two components: (a) a first component comprising a polymeric support with a multiplicity of ligands comprising a C10-C24 alkylamino group, the ligands specifically binding endotoxin; and (b) a second component comprising a halogenated quinolone moiety immobilized on an amino-group-containing solid support by the formation of an amide linkage, the first component and the second component being present in the resin at a ratio of from about 20:80 (v/v) to about 80:20 (v/v); and (2) collecting the biological fluid from which pyrogens have been removed. Preferably, the alkylamino group is a stearylamino group, and the ligands are cross-linked and quaternized by reaction with a dibromoalkanol. Preferably, the polymeric support of the first component is agarose in particulate form.
    Type: Application
    Filed: July 18, 2002
    Publication date: January 22, 2004
    Applicant: Clarigen Inc.
    Inventors: Marie-Claude Amoureux, Edit Hegyi, Peter Grandics, Susan Szathmary
  • Patent number: 6251409
    Abstract: The present invention provides a decorative cosmetic composition that is visually distinct comprising a translucent or transparent particle and a cosmetic base. In addition, the present invention provides a decorative cosmetic composition that has both a functional effect, such as for cleansing or massage, and a distinct visual effect.
    Type: Grant
    Filed: November 10, 1998
    Date of Patent: June 26, 2001
    Assignee: Clarigen, Inc.
    Inventors: Edit Hegyi, Susan Szathmary, Peter Grandics
  • Patent number: 6106723
    Abstract: A new method is described to produce large volumes of low cost water for injection directly from potable water in order to meet the needs of hemodialysis and other biological applications for ultrapure water. The source water is processed by a combination of membrane and chromatographic methods including reverse osmosis, ion exchange deionization, endotoxin-specific adsorption steps and polishing filtration to reduce contaminant levels below those specified by the US Pharmacopoiea. Endotoxin removal from dialysate was demonstrated. The endotoxin removing adsorbent also adsorbs LAL-negative pyrogens from the test samples.
    Type: Grant
    Filed: May 1, 1998
    Date of Patent: August 22, 2000
    Inventors: Peter Grandics, Susan Szathmary, Edit Hegyi